搜尋結果
Japan's Otsuka to stop development of Alzheimer's disease drug
Reuters· 16 小時前Japan's Otsuka Pharmaceutical said on Wednesday it would stop developing an experimental drug to treat agitation and restlessness ...
Update on cases of Legionnaires' disease
Bastillepost· 3 日前The Centre for Health Protection (CHP) of the Department of Health today (May 20) reported the ...
How Gene Editing Therapies Could Go Beyond Rare Diseases
Forbes· 7 日前Earlier this year, a group of scientists in the Netherlands used the gene editing tool CRISPR ...
Tick season has arrived. Protect yourself with these tips
Bastillepost· 5 日前Tick season is starting across the U.S., and experts are warning the bloodsuckers may be as ...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 2 日前"We have a lot of confidence in this 80 billion ambition because of the portfolio and the ...
This researcher studied happiness for 10 years to try and find it herself—now she has a new ...
CNBC· 13 小時前In 2013, Stephanie Harrison's life looked perfect on paper, but she was deeply unhappy ...
Council Post: Go Forth, And Fight Aging
Forbes· 2 日前Recently, he shared a paper in Nature Biotechnology with his hundreds of thousands of Twitter ...
AltruBio Gathers Funds as Biotechs Aim for Next Blockbuster Anti-Inflammatory Therapy
The Wall Street Journal· 2 日前Biotechnology startup AltruBio has secured fresh capital to develop a drug for ulcerative ...
Biogen to Pay Up to $1.8 Billion for Immune Drug Developer
Bloomberg· 16 小時前Have a confidential tip for our reporters? Biogen Inc. agreed to acquire Human Immunology ...
阿茲海默治療新選擇!國璽幹細胞間質幹細胞新藥獲發明專利
科技新報 TechNews· 3 日前國璽幹細胞今日收到智慧財產局第 I 841986 號發明專利,以高表現型間質幹細胞來治療前額顳葉失智症、 ...
disease 相關
廣告